Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)

Fig. 3

Immune-related lncRNAs signature (IRLS) is a prognostic biomarker for overall survival (OS) in TCGA-BLCA cohort. (AC ac) KM survival, risk score and time-dependent ROC curves of OS according to IRLS groups in TCGA-BLCA training (A), testing (B) and entire (C) cohort. The entire cohort was divided into the training and testing cohorts at 7:3 cut-off. The cohorts were all stratified at median cut-off of the IRLS risk-scores to form IRLS high-risk and low-risk groups. The AUC was assessed at 1, 3 and 5 years

Back to article page